Senti Biosciences is trading at $0.33, up +6.26% in pre-market, with no new company-specific announcement, earnings release, regulatory action, or other major catalyst identified for September 18, 2026.
- Recent financing and merger-related developments remain background context, including a $2.5 million equity commitment announced September 8.
- Broader pre-market sentiment is modestly positive, but available index gains do not clearly explain the move; confidence is low.